Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study

  • Patrick Vermersch1Email author,
  • Rabah Benrabah2,
  • Nicolas Schmidt3,
  • Hélène Zéphir1,
  • Pierre Clavelou4,
  • Cyrille Vongsouthi5,
  • Patrice Dubreuil6, 7,
  • Alain Moussy6 and
  • Olivier Hermine6, 8Email author
BMC Neurology201212:36

DOI: 10.1186/1471-2377-12-36

Received: 12 October 2011

Accepted: 27 April 2012

Published: 12 June 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
12 Oct 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
3 Nov 2011 Reviewed Reviewer Report - jean sibilia
15 Nov 2011 Reviewed Reviewer Report - B Sayed
15 Mar 2012 Author responded Author comments - Olivier Hermine
Resubmission - Version 3
15 Mar 2012 Submitted Manuscript version 3
17 Mar 2012 Author responded Author comments - Olivier Hermine
Resubmission - Version 4
17 Mar 2012 Submitted Manuscript version 4
9 Apr 2012 Reviewed Reviewer Report - B Sayed
20 Apr 2012 Reviewed Reviewer Report - jean sibilia
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
27 Apr 2012 Editorially accepted
12 Jun 2012 Article published 10.1186/1471-2377-12-36

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Neurology, University of Lille Nord de France (EA2686), Hôpital Roger Salengro, CHU de Lille
(2)
Private Practice
(3)
Private Practice, Rueil-Malmaison
(4)
Hôpital Gabriel Montpied
(5)
Private Practice
(6)
AB Science
(7)
Inserm U891, Centre de Recherche en Cancérologie de Marseille, Signalisation, Hematopoiesis and Mechanisms of Oncogenesis, Centre de référence des mastocytoses, Marseille, France; Institut PaoliCalmettes, Marseille, France, Université Méditerranée
(8)
Service d’hématologie adulte, Centre de référence des mastocytoses, CNRS UMR 8147, Hôpital Necker, Université Paris Descartes, 149 - 161 rue de Sèvres

Advertisement